Inventor · disambiguated record
Daniel Olal
Also filed as: OLAL DANIEL
3 granted patents·10 citations·filing 2013–2020
63Inventor score
Files withMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN1MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT1Max-Delbrück-Centrum für Molekulare Medizin 1
Top patents by PatentIndex Score
3 records- 0182US10189906B2Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseasesMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2013·Granted Jan 29, 2019·7 cites·8 claims
- 0279US10745486B2Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseasesMax-Delbrück-Centrum für Molekulare Medizin ·Filed 2018·Granted Aug 18, 2020·3 cites·9 claims
- 0365US11667722B2Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseasesMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2020·Granted Jun 6, 2023·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Daniel Olal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →